The invention discloses the use of a smilagenin in the treatment of cognitive disfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.

Die Erfindung gibt den Gebrauch von einem smilagenin in der Behandlung der kognitiven Funktionsstörung und der ähnlichen Bedingungen frei. Behandlungsmethoden und pharmazeutischer Aufbau wird auch freigegeben.
 
Web www.patentalert.com

< Methods and reagents for identifying inhibitors of proteolysis of membrane-associated proteins

< Composition for inhibiting production or secretion of amyloid .beta. protein to treat Down's syndrome

> .beta.-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions

> Transgenic animals harboring APP allele having swedish mutation
~ 00063